LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

Search

Phibro Animal Health Corp

Geschlossen

BrancheGesundheitswesen

40.45 2.04

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

39.1

Max

41.4

Schlüsselkennzahlen

By Trading Economics

Einkommen

9.3M

27M

Verkäufe

-15M

364M

KGV

Branchendurchschnitt

24

77.671

EPS

0.73

Dividendenrendite

1.23

Gewinnspanne

7.29

Angestellte

2,475

EBITDA

22M

63M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+19.14% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

1.23%

2.35%

Nächste Dividendenausschüttung

17. Dez. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-133M

1.6B

Vorheriger Eröffnungskurs

38.41

Vorheriger Schlusskurs

40.45

Nachrichtenstimmung

By Acuity

20%

80%

53 / 374 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bullish Evidence

Phibro Animal Health Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

10. Dez. 2025, 22:02 UTC

Ergebnisse

Synopsys Sees Strong 2026 as Ansys Acquisition Boosts 4Q Revenue

10. Dez. 2025, 21:46 UTC

Ergebnisse

Adobe Expects Double-Digit Recurring Revenue Growth Next Year

10. Dez. 2025, 23:52 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount Sends Letter to Warner Bros. Shareholders Saying Its Offer Is 'Superior' -- Barrons.com

10. Dez. 2025, 23:43 UTC

Market Talk

Nikkei May Rise After Fed Rate Cut -- Market Talk

10. Dez. 2025, 23:36 UTC

Market Talk

Gold Consolidates as Traders Digest FOMC Decision -- Market Talk

10. Dez. 2025, 23:20 UTC

Ergebnisse

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- 2nd Update

10. Dez. 2025, 23:15 UTC

Ergebnisse

Synopsys Targets Double-Digit Growth Following Ansys Acquisition -- Interview

10. Dez. 2025, 22:59 UTC

Market Talk
Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Adobe Expects Semrush Deal to Bring in New Users -- Market Talk

10. Dez. 2025, 22:45 UTC

Market Talk

Coca-Cola's New CEO Pick Looks A Lot Like The Last One -- Market Talk

10. Dez. 2025, 22:40 UTC

Ergebnisse

Synopsys Stock Rises on Earnings Beat, Higher Guidance -- Barrons.com

10. Dez. 2025, 22:06 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount Sends Letter to Warner Bros. Shareholders Saying Their Offer Is 'Superior' -- Barrons.com

10. Dez. 2025, 22:06 UTC

Ergebnisse

Oracle Reports Mixed Earnings. The Stock Is Falling. -- Barrons.com

10. Dez. 2025, 22:02 UTC

Ergebnisse

Synopsys Stock Rises on Earnings Beat, Higher Guidance -- Barrons.com

10. Dez. 2025, 22:00 UTC

Ergebnisse

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- Update

10. Dez. 2025, 21:53 UTC

Ergebnisse

Adobe Earnings Show 'Rapid Adoption' of AI Tools. The Stock Is Up. -- Barrons.com

10. Dez. 2025, 21:50 UTC

Akquisitionen, Fusionen, Übernahmen

Investors Bet That a Higher Bid for Warner Is Coming -- Update

10. Dez. 2025, 21:50 UTC

Market Talk
Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Financial Services Roundup: Market Talk

10. Dez. 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

10. Dez. 2025, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

10. Dez. 2025, 21:45 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount Sends Letter to Warner Bros. Shareholders Saying Their Offer Is 'Superior' -- Barrons.com

10. Dez. 2025, 21:33 UTC

Ergebnisse

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- WSJ

10. Dez. 2025, 21:32 UTC

Ergebnisse

Oracle Reports Mixed Earnings. The Stock Is Falling. -- Barrons.com

10. Dez. 2025, 21:28 UTC

Akquisitionen, Fusionen, Übernahmen

Sverica Capital Management Announces Sale of Coastal Cloud Holdings to Tata Consultancy Services for $700M

10. Dez. 2025, 21:25 UTC

Ergebnisse

Adobe Earnings Show 'Rapid Adoption' of AI Tools. The Stock Is Up. -- Barrons.com

10. Dez. 2025, 21:18 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount Skydance: Company Has Air Tight Financing to Deliver on Warner Bros. Offer >PSKY

10. Dez. 2025, 21:16 UTC

Ergebnisse

Oracle Reports Mixed Earnings. The Stock is Falling. -- Barrons.com

10. Dez. 2025, 21:15 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount Skydance: Public Offer for Warner Bros. Delivers Superior Value, Faster, More Certain Path to Completion

10. Dez. 2025, 21:15 UTC

Ergebnisse

Oracle: 'Sold Ampere Because We No Longer Think It Is Strategic for Us to Continue Designing, Manufacturing and Using Our Own Chips in Our Cloud Datacenters' >ORCL

10. Dez. 2025, 21:14 UTC

Ergebnisse

Oracle 2Q Non-GAAP Operating Income Was $6.7 B >ORCL

10. Dez. 2025, 21:14 UTC

Ergebnisse

Oracle 2Q GAAP Operating Income Was $4.7 B >ORCL

Peer-Vergleich

Kursveränderung

Phibro Animal Health Corp Prognose

Kursziel

By TipRanks

19.14% Vorteil

12-Monats-Prognose

Durchschnitt 47.5 USD  19.14%

Hoch 50 USD

Tief 45 USD

Basierend auf 2 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Phibro Animal Health Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

2 ratings

1

Buy

1

Halten

0

Sell

Technischer Score

By Trading Central

17 / N/AUnterstützung & Widerstand

Kurzfristig

Strong Bullish Evidence

Mittelfristig

Weak Bearish Evidence

Langfristig

Weak Bearish Evidence

Stimmung

By Acuity

53 / 374 Ranking in Gesundheitswesen

Nachrichtenstimmung

Sehr starke bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Phibro Animal Health Corp

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.
help-icon Live chat